SCHEMBL3230758

SCHEMBL3230758

CCC1NC(=O)C1CC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.40
MAPT P10636 2/20 0.40
ITGB3 P05106 1/20 0.39
ITGB2 P05107 1/20 0.39
ITGB1 P05556 1/20 0.39
ITGAV P06756 1/20 0.39
ITGA2B P08514 1/20 0.39
ITGA5 P08648 1/20 0.39
ITGB5 P18084 1/20 0.39
ITGAL P20701 1/20 0.39
TSHR P16473 2/20 0.37
KDM4E B2RXH2 1/20 0.37
AKR1C4 P17516 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
TDP1 Q9NUW8 1/20 0.32
ABL1 P00519 1/20 0.31
IDE P14735 1/20 0.31
PPARG P37231 1/20 0.31
RIN1 Q13671 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1029523 0.85 MAPT (0.38) HTTMAPTITGB3ITGB2ITGB1
SCHEMBL10852667 0.84 HTT (0.40) HTTMAPTITGB3ITGB2ITGB1
SCHEMBL11241409 0.84 HTT (0.40) HTTMAPTITGB3ITGB2ITGB1
SCHEMBL10854263 0.84 HTT (0.40) HTTMAPTITGB3ITGB2ITGB1
SCHEMBL10853447 0.84 HTT (0.40) HTTMAPTITGB3ITGB2ITGB1
SCHEMBL10857021 0.84 HTT (0.40) HTTMAPTITGB3ITGB2ITGB1
SCHEMBL10857737 0.74 HTT (0.33) HTTMAPTITGB3ITGB2ITGB1
SCHEMBL10850753 0.74 HTT (0.33) HTTMAPTITGB3ITGB2ITGB1
SCHEMBL16421034 0.71 ITGB1 (0.42) HTTMAPTITGB3ITGB2ITGB1
SCHEMBL3759735 0.71 EGFR (0.48) MAPTTDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010014909-A1 IMMUNOMODULATORY PEPTIDES SYNTONIX PHARMACEUTICALS, INC. (US) 2010-02-04 WO disclosed
EP-1370276-A2 MEDICAL USES OF INTERCELLULAR COMMUNICATION FACILITATING COMPOUNDS Zealand Pharma A/S (DK) 2003-12-17 EP disclosed
WO-2002077017-A2 MEDICAL USES OF INTERCELLULAR COMMUNICATION FACILITATING COMPOUNDS ZEALAND PHARMA A/S (DK) 2002-10-03 WO disclosed